Sagent Pharmaceuticals, Inc. (SGNT) Reports Q2 EPS Loss of $0.37, Revenues Grow 205%
Go back to Sagent Pharmaceuticals, Inc. (SGNT) Reports Q2 EPS Loss of $0.37, Revenues Grow 205%| SAGENT PHARMA (NASDAQ: SGNT) | Delayed: 21.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.76 | 52 Week High | $21.88 | |||
| Open | $0.00 | 52 Week Low | $10.55 | |||
| Day High | $21.76 | P/E | 21.98 | |||
| Day Low | $21.76 | EPS | $0.99 | |||
| Volume | 51,000 | |||||
